Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Andrew Astor Biography and Net Worth

CEO of Nephros

An entrepreneurial technology executive with over 35 years of operating and financial experience, Andy Astor joined Nephros in early 2017, as Chief Financial Officer. He was named Chief Operating Officer in 2019, and Chief Executive Officer and Director in August 2020. Prior to Nephros, he was President and CFO of OpenSCG, a software technology firm that was acquired in 2018 by Amazon Web Services. From 2013 to 2015, Mr. Astor was Managing Director at Synechron, a global technology consultancy. From 2009 to 2013, he was Vice President, Technology at Asurion, where he led a 1,000-staff software development division. From 2004 to 2008, he was co-founder and CEO of EnterpriseDB, an open-source software firm for which he raised over $25 million in venture capital and spearheaded strategic partnerships with IBM and NTT Data. From 2002 to 2004 Mr. Astor was Vice President of Web Services Strategy at webMethods, a publicly traded company that was subsequently acquired by Software AG for $546 million. While at webMethods Mr. Astor also served on the Board of Directors of the Web Services Interoperability Organization (WS-I). Prior to that, he spent several years as Vice President of Transactional Products at Dun & Bradstreet (NYSE: DNB), and held various roles at Ernst & Young, MCI Systemhouse, and American Management Systems. Mr. Astor received his Bachelor of Arts in Mathematics from Clark University and his MBA from The Wharton School at the University of Pennsylvania.

What is Andrew Astor's net worth?: The estimated net worth of Andrew Astor is at least $152,425.16 as of August 17th, 2021. Mr. Astor owns 75,458 shares of Nephros stock worth more than $152,425 as of April 18th. This net worth estimate does not reflect any other investments that Mr. Astor may own. Learn More about Andrew Astor's net worth.
How do I contact Andrew Astor?: The corporate mailing address for Mr. Astor and other Nephros executives is 380 LACKAWANNA PLACE, SOUTH ORANGE NJ, 07079. Nephros can also be reached via phone at (201) 343-5202 and via email at [email protected]. Learn More on Andrew Astor's contact information.
Has Andrew Astor been buying or selling shares of Nephros?: Andrew Astor has not been actively trading shares of Nephros over the course of the past ninety days. Most recently, on Tuesday, August 17th, Andrew Astor bought 2,500 shares of Nephros stock. The stock was acquired at an average cost of $7.67 per share, with a total value of $19,175.00. Following the completion of the transaction, the chief executive officer now directly owns 75,458 shares of the company's stock, valued at $578,762.86. Learn More on Andrew Astor's trading history.
Who are Nephros' active insiders?: Nephros' insider roster includes Andrew Astor (CEO), Tom Gwydir (Director), and Wesley Lobo (CMO). Learn More on Nephros' active insiders.
Are insiders buying or selling shares of Nephros?: During the last year, Nephros insiders bought shares 2 times. They purchased a total of 18,099 shares worth more than $39,748.50. The most recent insider tranaction occured on December, 7th when CEO Robert R Jr. Banks bought 18,000 shares worth more than $39,600.00. Insiders at Nephros own 5.1% of the company. Learn More about insider trades at Nephros.
Information on this page was last updated on 12/7/2023.

Andrew Astor Insider Trading History at Nephros

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/17/2021	Buy	2,500	$7.67	$19,175.00	75,458
11/19/2020	Buy	1,000	$5.87	$5,870.00	72,958
8/19/2020	Buy	950	$7.40	$7,030.00	71,958
5/28/2020	Buy	1,000	$7.80	$7,800.00
8/22/2019	Buy	1,500	$6.97	$10,455.00
6/14/2019	Buy	35,000	$0.64	$22,400.00
4/10/2018	Buy	80,000	$0.45	$36,000.00
3/9/2018	Buy	5,000	$0.48	$2,400.00
12/4/2017	Buy	18,333	$0.50	$9,166.50
8/28/2017	Buy	10,000	$0.27	$2,700.00	186,709
8/11/2017	Buy	20,000	$0.26	$5,200.00	186,666

Andrew Astor Buying and Selling Activity at Nephros

Nephros Company Overview

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Today's Range

Now: $2.02

$1.99

$2.19

50 Day Range

MA: $2.69

$1.99

$3.72

2 Week Range

Now: $2.02

$1.13

$4.04

Volume

5,942 shs

Average Volume

19,541 shs

Market Capitalization

$21.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad